Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-10-30

FDA Approved: CEREZYME — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

FDA approved a supplemental application for Cerezyme (imiglucerase) from Genzyme Corporation, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEREZYME (imiglucerase)

Snippet

SUPPL AP for CEREZYME (IMIGLUCERASE)